Laboratorio di Patologia Clinica, Ospedale San Antonio, Azienda Sanitaria Universitaria Integrata di Udine, Tolmezzo, Italy.
Laboratorio Diagnostico di Autoimmunologia, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Sci Rep. 2020 May 8;10(1):7748. doi: 10.1038/s41598-020-64550-y.
A dense fine speckled pattern (DFS) caused by antibodies to the DFS70 kDa nuclear protein is a relatively common finding while testing for anti-nuclear antibodies (ANA) by indirect immunofluorescence (IIF) on HEp-2 cells. However, despite many efforts and numerous studies, the clinical significance of anti-DFS70 antibodies is still unknown as they can be found in patients with various disorders and even in healthy subjects. In this study we aimed at verifying whether these antibodies are associated with thrombotic events or with unexplained recurrent pregnancy loss (RPL). We studied 443 patients with venous or arterial thrombosis or RPL and 244 controls by IIF on HEp-2 cells and by a DFS70-specific chemiluminescent immunoassay (CIA). The DFS pattern was observed in IIF in 31/443 (7.0%) patients and in 6/244 (2.5%) controls (p = 0.01) while anti-DFS70 specific antibodies were detected by CIA in 11 (2.5%) patients and in one (0.4%) control (p = 0.06). Positive samples, either by IIF or by CIA, were then assayed by a second DFS70-specific line-immunoassay (LIA) method: 83.3% of the CIA positive samples were confirmed DFS70 positive versus only 29.7% of the IIF positive samples. These findings show that IIF overestimates anti-DFS70 antibody frequency and that results obtained by specific CIA and LIA assays do not indicate that venous or arterial thrombosis or RPL are linked to a higher prevalence of anti-DFS70 antibodies.
在使用人喉癌细胞(HEp-2)细胞间接免疫荧光法(IIF)检测抗核抗体(ANA)时,一种由抗 DFS70 核蛋白抗体引起的密集细点状模式(DFS)是一种相对常见的发现。然而,尽管进行了许多努力和大量研究,抗 DFS70 抗体的临床意义仍然未知,因为它们可以在患有各种疾病的患者中甚至在健康受试者中发现。在这项研究中,我们旨在验证这些抗体是否与血栓事件或不明原因的复发性妊娠丢失(RPL)有关。我们通过 IIF 在 HEp-2 细胞上和 DFS70 特异性化学发光免疫分析(CIA)研究了 443 例静脉或动脉血栓形成或 RPL 患者和 244 例对照者。在 IIF 中观察到 DFS 模式在 31/443(7.0%)患者和 6/244(2.5%)对照者中(p=0.01),而通过 CIA 检测到抗 DFS70 特异性抗体在 11 例(2.5%)患者和 1 例(0.4%)对照者中(p=0.06)。然后通过第二种 DFS70 特异性线免疫分析(LIA)方法对阳性样本进行检测:CIA 阳性样本中有 83.3%被确认为 DFS70 阳性,而 IIF 阳性样本中只有 29.7%。这些发现表明,IIF 高估了抗 DFS70 抗体的频率,并且通过特异性 CIA 和 LIA 检测获得的结果表明静脉或动脉血栓形成或 RPL 与抗 DFS70 抗体的更高患病率无关。